Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy.
about
Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococciSurface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunizationOxidative depolymerization of polysaccharides by reactive oxygen/nitrogen speciesGroup B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity.Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines.Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbits.Synthetically defined glycoprotein vaccines: current status and future directions.The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo.
P2860
Q30799389-0A42F69C-507A-4B80-821B-51D0D29CB2FDQ33538951-7308A100-67DB-4750-8DA4-3DE7B440505DQ34005612-8F5633D6-B2B2-4366-ABF5-58099E7FBF5AQ34661527-E2DE641C-2FE7-40DA-A109-3EFEF771C92FQ34975076-58D88BCC-653D-4952-A2BB-4C5F62C286D4Q35126742-AD84FA00-F4FC-4EFF-A325-CB48AA3A363EQ35801994-D5E0EE4C-43DD-4C88-B06F-89E3907BC776Q37074015-1860E87A-684F-43DD-995C-9FAC07166E25Q37242954-434DAC8F-667F-4063-90C0-E875F57242F6Q39375701-8CC25F49-E0F1-4966-ADF5-8361A471C80BQ47245287-0CD526A2-6C73-473C-8261-6CC6ACB90C5AQ48505004-756565A0-DCE8-4B16-8196-AD2C690FD66B
P2860
Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Structural properties of group ...... e immunogenicity and efficacy.
@ast
Structural properties of group ...... e immunogenicity and efficacy.
@en
type
label
Structural properties of group ...... e immunogenicity and efficacy.
@ast
Structural properties of group ...... e immunogenicity and efficacy.
@en
prefLabel
Structural properties of group ...... e immunogenicity and efficacy.
@ast
Structural properties of group ...... e immunogenicity and efficacy.
@en
P2093
P2860
P1476
Structural properties of group ...... ce immunogenicity and efficacy
@en
P2093
A J D'Ambra
D L Kasper
H K Guttormsen
L C Paoletti
M R Wessels
P2860
P304
P407
P577
1998-05-01T00:00:00Z